Patents
ev3 Inc. Reports Third Quarter Financial Results
Published in Medical Patent Business Week, November 16th, 2007
As previously reported, ev3's net sales in the third quarter of 2007 increased 25% to approximately $65.1 million versus net sales of $51.9 million in the third quarter of 2006. The company's guidance range for third quarter net sales was $64 to $68 million. This third quarter sales growth reflected a strong contribution from ev3's peripheral vascular and neurovascular business segments as well as domestic and international markets.
Jim Corbett, chairman, president and CEO of ev3 Inc., commented, "We are pleased with our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- Algorithms
Entry of Biogenerics and Decreasing Use of Amgen's Epogen and Johnson & Johnson's Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016 - Algorithms
Scientists at Dongguk University detail research in algorithms - Antisense Technology
Ryogen Gets Patent on Soluble Aminopeptidase P Gene - Arthritis
Cytokine Announces Oral Efficacy of Anti-Cytokine Semapimod - Atherectomy
Spectranetics Reports Third Quarter Revenue of $21.2 Million as Atherectomy Product Sales Increase 42% - Bioinformatics
Cell Signaling Technology Announces the Availability of PhosphoScan(R) Profiling Technology and PhosphoSite(R) Knowledgebase to Academic Researchers - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
